News
The news comes days after Novo cut its full-year outlook due to rising competition from copycat compounders, and named a new ...
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
Ali Eastburn missed her son’s rehearsal dinner after her appendix burst while traveling, an incident she claims was caused by ...
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...
And it’s a problem with humankind in general. We do tend to crave quick fixes, often in pharmaceutical form. That’s why Henry ...
European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
With 14 new lawsuits filed and 132 total complaints across 40 states, Novo Nordisk is intensifying efforts to protect ...
A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain ...
Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of 2025, confirming investor ...
Sales of Novo Nordisk’s diabetes drugs including Ozempic slowed to grow at 8 per cent year on year in the first half, down sharply from its rate last year, as the company loses market share to rival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results